Edwards Lifesciences EBITDA 2010-2024 | EW

Edwards Lifesciences annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Edwards Lifesciences EBITDA for the quarter ending September 30, 2024 was $0.385B, a 4.39% decline year-over-year.
  • Edwards Lifesciences EBITDA for the twelve months ending September 30, 2024 was $1.773B, a 10.17% increase year-over-year.
  • Edwards Lifesciences 2023 annual EBITDA was $1.679B, a 11.07% decline from 2022.
  • Edwards Lifesciences 2022 annual EBITDA was $1.888B, a 3.45% increase from 2021.
  • Edwards Lifesciences 2021 annual EBITDA was $1.825B, a 81.64% increase from 2020.
Edwards Lifesciences Annual EBITDA
(Millions of US $)
2023 $1,679
2022 $1,888
2021 $1,825
2020 $1,005
2019 $1,236
2018 $826
2017 $1,171
2016 $855
2015 $709
2014 $561
2013 $535
2012 $474
2011 $358
2010 $341
2009 $297
Edwards Lifesciences Quarterly EBITDA
(Millions of US $)
2024-09-30 $385
2024-06-30 $409
2024-03-31 $426
2023-12-31 $553
2023-09-30 $403
2023-06-30 $300
2023-03-31 $424
2022-12-31 $483
2022-09-30 $438
2022-06-30 $494
2022-03-31 $474
2021-12-31 $407
2021-09-30 $424
2021-06-30 $578
2021-03-31 $416
2020-12-31 $384
2020-09-30 $383
2020-06-30 $-145
2020-03-31 $383
2019-12-31 $335
2019-09-30 $317
2019-06-30 $289
2019-03-31 $295
2018-12-31 $15
2018-09-30 $268
2018-06-30 $271
2018-03-31 $272
2017-12-31 $326
2017-09-30 $248
2017-06-30 $268
2017-03-31 $330
2016-12-31 $191
2016-09-30 $214
2016-06-30 $233
2016-03-31 $218
2015-12-31 $189
2015-09-30 $174
2015-06-30 $164
2015-03-31 $181
2014-12-31 $169
2014-09-30 $148
2014-06-30 $135
2014-03-31 $110
2013-12-31 $145
2013-09-30 $123
2013-06-30 $141
2013-03-31 $126
2012-12-31 $155
2012-09-30 $109
2012-06-30 $110
2012-03-31 $100
2011-12-31 $101
2011-09-30 $74
2011-06-30 $90
2011-03-31 $93
2010-12-31 $96
2010-09-30 $81
2010-06-30 $87
2010-03-31 $77
2009-12-31 $79
2009-09-30 $72
2009-06-30 $77
2009-03-31 $69
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $43.285B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $204.963B 25.00
Intuitive Surgical (ISRG) United States $191.657B 100.20
Alcon (ALC) Switzerland $42.325B 28.32
IQVIA Holdings (IQV) United States $36.881B 20.32
IDEXX Laboratories (IDXX) United States $36.416B 42.88
DexCom (DXCM) United States $31.017B 46.71
Waters (WAT) United States $23.177B 34.27
STERIS (STE) Ireland $21.145B 24.34
SONOVA HOLDING (SONVY) Switzerland $19.889B 0.00
Hologic (HOLX) United States $17.436B 18.83
Fresenius Medical Care AG KGaA (FMS) Germany $14.025B 14.40
Sysmex ADR (SSMXY) Japan $12.739B 39.95
Globus Medical (GMED) United States $11.287B 28.58
Masimo (MASI) United States $9.351B 45.25
Penumbra (PEN) United States $9.298B 91.08
Teleflex (TFX) United States $8.663B 13.82
Glaukos (GKOS) United States $7.520B 0.00
PROCEPT BioRobotics (PRCT) United States $4.758B 0.00
Integer Holdings (ITGR) United States $4.684B 26.55
Veracyte (VCYT) United States $3.331B 99.95
Inari Medical (NARI) United States $3.223B 0.00
LivaNova (LIVN) United Kingdom $2.717B 15.69
Nihon Kohden (NHNKY) Japan $2.514B 19.10
TransMedics (TMDX) United States $2.315B 73.39
Elekta AB (EKTAY) Sweden $2.239B 20.13
Tandem Diabetes Care (TNDM) United States $2.221B 0.00
Integra LifeSciences Holdings (IART) United States $1.853B 9.68
RxSight (RXST) United States $1.579B 0.00
Alphatec Holdings (ATEC) United States $1.369B 0.00
Artivion (AORT) United States $1.250B 82.86
OPKO Health (OPK) United States $1.065B 0.00
Pulse Biosciences (PLSE) United States $1.025B 0.00
Paragon 28 (FNA) United States $0.879B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.859B 14.60
ORTHOFIX MEDICAL INC (OFIX) United States $0.709B 0.00
IRadimed (IRMD) United States $0.701B 37.88
Mesa Laboratories (MLAB) United States $0.700B 16.50
AxoGen (AXGN) United States $0.653B 0.00
Pacific Biosciences Of California (PACB) United States $0.641B 0.00
SiBone (SIBN) United States $0.596B 0.00
OrthoPediatrics (KIDS) United States $0.556B 0.00
Semler Scientific (SMLR) United States $0.496B 29.18
Treace Medical Concepts (TMCI) United States $0.492B 0.00
ClearPoint Neuro (CLPT) United States $0.460B 0.00
Tactile Systems Technology (TCMD) United States $0.449B 24.29
Delcath Systems (DCTH) United States $0.373B 0.00
AngioDynamics (ANGO) United States $0.361B 0.00
NeuroPace (NPCE) United States $0.344B 0.00
CVRx (CVRX) United States $0.330B 0.00
Inogen (INGN) United States $0.231B 0.00
Alpha Tau Medical (DRTS) Israel $0.212B 0.00
Accuray (ARAY) United States $0.208B 0.00
Sight Sciences (SGHT) United States $0.198B 0.00
KORU Medical Systems (KRMD) United States $0.180B 0.00
Nevro (NVRO) United States $0.163B 0.00
Atossa Genetics (ATOS) United States $0.159B 0.00
Sensus Healthcare (SRTS) United States $0.145B 15.56
Spectral Diagnostics (EDTXF) Canada $0.106B 0.00
WORK Medical Technology Group (WOK) China $0.093B 0.00
Monogram Orthopaedics (MGRM) United States $0.092B 0.00
Vicarious Surgical (RBOT) United States $0.091B 0.00
LENSAR (LNSR) United States $0.088B 0.00
EDAP TMS S.A (EDAP) France $0.085B 0.00
908 Devices (MASS) United States $0.084B 0.00
InspireMD (NSPR) Israel $0.082B 0.00
Hyperfine (HYPR) United States $0.072B 0.00
Covalon Technologies (CVALF) Canada $0.070B 0.00
EnVVeno Medical (NVNO) United States $0.052B 0.00
Lucid Diagnostics (LUCD) United States $0.047B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.043B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Accelerate Diagnostics (AXDX) United States $0.036B 0.00
Adagio Medical Holdings (ADGM) United States $0.035B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Precision Optics (POCI) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.024B 0.00
NexGel (NXGL) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.022B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00